May 25, 2011 - The U.S. Food and Drug Administration (FDA) has given 510(k) clearance and commercial availability of the Fujifilm Medical Systems’s FDR D-EVO Wireless. This new wireless version of the company's flat panel detector will deliver Fujifilm's image quality in a lightweight design for enhanced versatility and greater ease of positioning in a wider variety of imaging applications. The FDR D-EVO Wireless will be featured along with Fujifilm's complete product line-up, including the Synapse portfolio, at the Society for Imaging Informatics in Medicine (SIIM) 2011 Annual Meeting June 2-5 in Washington, D.C.
Like its corded predecessor, the FDR D-EVO, the FDR D-EVO Wireless offers Fujifilm's image quality while also enabling facilities to achieve significant dose efficiency improvements. The flat panel detector uses Fujifilm's patented Irradiation Side Sampling (ISS), a technology that improves detective quantum efficiency (DQE) and enables technologists to take high-quality images at lower doses. This design reduces scatter and blur of X-rays captured, resulting in sharper images with greater detail, which enhances diagnostic confidence for the radiologist. The wireless detector is the ideal solution for exams where low-dose is required to produce the fine details for images of delicate areas, such as orthopaedic exams of the wrist, hand or leg.
In addition to providing flexibility during an exam with its light weight and no cord to interfere, the FDR D-EVO Wireless also offers a lasting power supply that will reduce downtime and increase throughput. The system offers a lightweight removable lithium ion battery that provides fast charge times and up to three hours or 400 exposures of use per charge. A multi-charger system with two spare batteries is also included with the detector, which reduces concerns for power loss. Additionally, a detachable cord provides the option for continuous charging and the ability to leave the detector in the bucky for uninterrupted extended use.
For more information: www.fujimed.com
July 18, 2024 
